Medication info
Teriphthine M Extended-Release Tablet 10/750 mg

Teriphthine M Extended-Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›750mg / 1 tabletTeneligliptin Ditosylate Dihydrate›18.92mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202706 · Approved 2022.07.01 · Insurance code 642405040

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take two tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from concomitant therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin that the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because changes may affect blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is an adjunct to diet and exercise for better blood sugar control in patients with type 2 diabetes. Teneligliptin and Metformin work together to help effectively manage blood sugar levels. By doing so, it helps maintain stable blood sugar levels, thereby contributing to the prevention of complications. Therefore, it is a very useful drug in the treatment of type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take two tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from concomitant therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin that the patient was previously taking. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Because changes may affect blood glucose control, any change in treatment for patients with type 2 diabetes should be made with careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for blood sugar control and can rarely cause a serious metabolic complication known as lactic acidosis. The risk of lactic acidosis is higher in patients with impaired kidney function or weak heart and liver function, so caution is needed. This medication should not be used in patients with moderate or severe renal impairment, patients with severe heart failure, or patients at risk of acute kidney injury. Additionally, this medication should be temporarily discontinued before and after procedures using radiologic contrast agents. Depending on the type of diabetes, there may be cases where this medication is not used, so patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. The risk of hypoglycemia may increase when this medication is used together with insulin or sulfonylureas, so patients should be well aware of hypoglycemic symptoms and take appropriate measures immediately if they occur. Patients with impaired liver function, severe lung disease, excessive alcohol consumption, or dehydration also need to be cautious when using this medication. Pregnant women or women who may become pregnant are advised not to use this medication, and nursing mothers should consult a physician regarding the use of this medication. When administered to elderly patients, regular monitoring of kidney function and appropriate dosage adjustments are necessary. In case of overdose, seek immediate medical attention for appropriate treatment, and drug removal can be achieved through hemodialysis. This medication should be kept out of reach of children and should not be transferred to other containers for safety. During the use of this medication, it may be temporarily discontinued during acute infections, severe trauma, or pre- and post-surgery when the physical condition is unstable, and any abnormal symptoms should be reported to healthcare professionals immediately.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
Show 129 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • elevated GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • lethargy
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory tract infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • blood sugar abnormalities
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal stenosis
  • intravertebral disc protrusion
  • intervertebral disc disorders
  • spinal ligament ossification
  • spinal foramen stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary stones
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • chronic gastritis
  • dysentery
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal-rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • hemorrhage
  • increased blood sugar
  • abnormal sputum
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • contusion
  • hives
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • hearing loss
  • endolymphatic hydrops
  • ovarian cysts
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps to maintain the drug's effectiveness.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.